SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-11-064151
Filing Date
2011-07-06
Accepted
2011-07-06 17:09:53
Documents
5
Period of Report
2011-06-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a59833e8vk.htm 8-K 32307
2 EX-10.1 a59833exv10w1.htm EX-10.1 695984
3 EX-99.1 a59833exv99w1.htm EX-99.1 7025
4 GRAPHIC a59833a5983300.gif GRAPHIC 10317
5 GRAPHIC a59833a5983301.gif GRAPHIC 3509
  Complete submission text file 0000950123-11-064151.txt   756015
Mailing Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000
Business Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000 905 286-3000
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 11954077
SIC: 2834 Pharmaceutical Preparations